StockData
Utah Medical Products Inc logo

Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$70.96−1.28 (-1.77%)

Close on Nov 19, 2026Market cap $225.92MP/E 21.6Yield –

Utah Medical Products free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Utah Medical Products's free cash flow for the twelve months ending Jun 30, 2026 was $11.45M. For fiscal 2025 it was $14.32M, down 1.9% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is $21.64M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.32M-1.9%
FY2024Dec 31, 2024$14.60M-32.5%
FY2023Dec 31, 2023$21.64M+6.4%
FY2022Dec 31, 2022$20.34M-1.5%
FY2021Dec 31, 2021$20.65M+7.1%
FY2020Dec 31, 2020$19.28M+16.7%
FY2019Dec 31, 2019$16.52M+0.5%
FY2018Dec 31, 2018$16.43M+7.3%
FY2017Dec 31, 2017$15.31M+36.3%
FY2016Dec 31, 2016$11.24M-17.5%
FY2015Dec 31, 2015$13.63M-4.6%
FY2014Dec 31, 2014$14.28M+19.3%
FY2013Dec 31, 2013$11.97M-10.1%
FY2012Dec 31, 2012$13.31M+19.7%
FY2011Dec 31, 2011$11.12M+97.7%
FY2010Dec 31, 2010$5.63M-16.8%
FY2009Dec 31, 2009$6.76M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.25M-55.7%
Q1 FY2026Mar 31, 2026$2.98M-30.4%
Q4 FY2025Dec 31, 2025$3.37M-35.7%
Q3 FY2025Sep 30, 2025$3.85M-22.0%
Q2 FY2025Jun 30, 2025$2.82M-38.6%
Q1 FY2025Mar 31, 2025$4.28M-37.7%
Q4 FY2023Dec 31, 2023$5.24M-7.1%
Q3 FY2023Sep 30, 2023$4.94M-6.3%
Q2 FY2023Jun 30, 2023$4.59M-0.6%
Q1 FY2023Mar 31, 2023$6.87M+42.9%
Q4 FY2022Dec 31, 2022$5.64M+19.2%
Q3 FY2022Sep 30, 2022$5.27M-10.9%
Q2 FY2022Jun 30, 2022$4.62M+3.1%
Q1 FY2022Mar 31, 2022$4.81M-12.9%
Q4 FY2021Dec 31, 2021$4.73M-17.3%
Q3 FY2021Sep 30, 2021$5.91M+20.4%
Q2 FY2021Jun 30, 2021$4.48M+31.0%
Q1 FY2021Mar 31, 2021$5.52M+5.8%
Q4 FY2020Dec 31, 2020$5.72M+6.9%
Q3 FY2020Sep 30, 2020$4.91M-21.4%
Q2 FY2020Jun 30, 2020$3.42M+118.5%
Q1 FY2020Mar 31, 2020$5.22M+55.9%
Q4 FY2019Dec 31, 2019$5.35M+23.5%
Q3 FY2019Sep 30, 2019$6.25M+37.4%
Q2 FY2019Jun 30, 2019$1.57M-60.4%
Q1 FY2019Mar 31, 2019$3.35M-6.8%
Q4 FY2018Dec 31, 2018$4.34M+37.1%
Q3 FY2018Sep 30, 2018$4.55M+0.6%
Q2 FY2018Jun 30, 2018$3.95M+16.7%
Q1 FY2018Mar 31, 2018$3.59M-15.3%
Q4 FY2017Dec 31, 2017$3.16M+861.1%
Q3 FY2017Sep 30, 2017$4.52M+39.9%
Q2 FY2017Jun 30, 2017$3.39M-5.2%
Q1 FY2017Mar 31, 2017$4.24M+3.4%
Q4 FY2016Dec 31, 2016$329.00K-91.5%
Q3 FY2016Sep 30, 2016$3.23M–
Q2 FY2016Jun 30, 2016$3.57M–
Q1 FY2016Mar 31, 2016$4.10M–
Q4 FY2015Dec 31, 2015$3.88M–

More Utah Medical Products figures

See a number that looks wrong?